Michelle McMurry-Heath, M.D., has resigned as CEO of the Biotechnology Innovation Organization (BIO). The news comes just days after a report detailed clashes between her and the organization’s board.
ImmunityBio Chief Executive Officer Richard Adcock acknowledges the frustration with how long it’s taken getting the Dunkirk ...
The new CEO has at least five years and a large M&A war chest to position Sanofi for life after the loss of exclusivity on ...
SAN DIEGO--(BUSINESS WIRE)--Epirium Bio, Inc. (Epirium), a biopharmaceutical company advancing medicines for neuromuscular and fibrotic diseases, is pleased to announce two significant milestones that ...
Nearly 20 years ago, Gina Ford left Texas to continue her career in the biosciences. Ford, a pharmacist by training, spent 16 ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Uniquity Bio appoints Will Kane ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The CEO of the Biotech Innovation Organization (BIO), one of the top lobbying groups for the biopharma industry, is on leave amid internal dissent over her leadership, The Wall Street Journal reported ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Most of Kelderman's pay was in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results